15 High Growth Mega Cap Stocks You Can Buy and Hold For Next 3 Years

Page 6 of 13

8. Eli Lilly and Company (NYSE:LLY)

Number of Hedge Fund Holdings: 119

During the first quarter, eCIO Inc. acquired a new position in Eli Lilly and Company (NYSE:LLY) through the purchase of 886 shares. According to the latest disclosure with the SEC, the firm’s investment in the company is valued at approximately $732,000.

At a time when being lean is the new luxury, Eli Lilly and Company (NYSE:LLY) is doing what it does best. The company is focusing on obesity and type 2 diabetes treatment markets at a speed only a few can match. While the tirzepatide franchise captures the GLP-1 market, the company’s orforglipron, an experimental drug, continues to be more effective than the competitor’s Rybelsus.

The comparative statistics are a testament to the company’s strong market standing, with its 3-year and 5-year returns surpassing the market’s returns by 78.37% and 332.72%, respectively. With confidence around the oral GLP-1 segment, entering a pivotal stage of growth in 2026 onwards, we can only expect Eli Lilly and Company (NYSE:LLY) to outperform.

Eli Lilly and Company (NYSE:LLY) is an Indiana-based company that specializes in human pharmaceuticals. Founded in 1876, the company is committed to making life better for people all over the globe.

Page 6 of 13